viewer
SK Bioscience’s stock price, which has been hitting a record price of 63 trillion won in margin, is going downhill day after day. With the stock price falling for six consecutive trading days after the ceiling on the listing date, the sighs of individual investors who bought the peak are deepening.
According to the Korea Exchange on the 27th, on the 26th, SK Biosciences finished trading at 132,000 won, down 2.94% from the previous trading day. SK Bioscience, which was regarded as an IPO in the first half of this year, was a box office hit with a so-called ‘dasang’ that sets the upper limit after the initial price on the date of listing was doubled that of the public offering price. However, from the 19th, the second day of listing, the stock price fell 21.89% for six days, and the initial date of listing was close to 130,000 won.
In the midst of this, individual investors steadily bought SK Bioscience. Individuals net bought 29.8 billion won worth of KRW 169,000, which was the upper limit on the first day of listing. Although it closed down 1.48%, it net bought 167.9 billion won on the day after listing, when the closing price remained in the 160,000 won range. In particular, on the second day of listing, the stock price soared to 190,000 won during the day. In this way, SK Bioscience stocks net purchases by individuals during the initial two days of listing amount to 197.7 billion won. For two days, the ants received net sales worth 136.3 billion won and 43 billion won, respectively, at the peak of foreigners and institutions.
/ Reporter Shim Woo-il [email protected]
< 저작권자 ⓒ 서울경제, 무단 전재 및 재배포 금지 >